Long‐term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome

References

• Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–1638. doi:10.1056/NEJMoa021423
   PubMed Web of Science ®Google Scholar
• World Cancer Report Boyle P, Bernard L, editors. Eds. Cedex, France, World Health Organization, International Agency for Research on Cancer. 2008; Available from http://www.iarc.fr/en/publications/pdfs-online/wcr/index.php.
   Google Scholar
• Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654–2664. doi:10.1001/jama.298.22.2654
   PubMed Web of Science ®Google Scholar
• Foy CG, Bell RA, Farmer DF, Goff DC, Wagenknecht LE. Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2005;28:2501–2507. doi:10.2337/diacare.28.10.2501
   PubMed Web of Science ®Google Scholar
• Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective London, World cancer research fund, American institute for cancer research. 2007; Available from http://www.dietandcancerreport.org. Accessed April 17, 2020.
   Google Scholar
• Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197–208. doi:10.1016/j.cell.2009.12.052
   PubMed Web of Science ®Google Scholar
• Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–591. doi:10.1038/nrc1408
   PubMed Web of Science ®Google Scholar
• Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296:193–201.
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–1033. doi:10.1126/science.1160809
   PubMed Web of Science ®Google Scholar
• Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009;16:1103–1123. doi:10.1677/ERC-09-0087
   PubMed Web of Science ®Google Scholar
• Cox ME, Gleave ME, Zakikhani M, et al. Insulin receptor expression by human prostate cancers. Prostate. 2009;69:33–40. doi:10.1002/pros.20852
   PubMed Web of Science ®Google Scholar
• Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102–2107. doi:10.2337/dc06-0560
   PubMed Web of Science ®Google Scholar
• Kim JH, Lim YJ, Kim Y-H, et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev. 2007;16:1543–1546. doi:10.1158/1055-9965.EPI-07-0199
   PubMed Web of Science ®Google Scholar
• Denley A, Carroll JM, Brierley GV, et al. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol. 2007;27:3569–3577. doi:10.1128/MCB.01447-06
   PubMedGoogle Scholar
• Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131:3109S–3120S. doi:10.1093/jn/131.11.3109S
   PubMed Web of Science ®Google Scholar
• Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab. 2006;17:328–336. doi:10.1016/j.tem.2006.08.006
   PubMed Web of Science ®Google Scholar
• Paonessa F, Foti D, Costa V, et al. Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer. Cancer Res. 2006;66(10):5085–5093. doi:10.1158/0008-5472.CAN-05-3678
   PubMed Web of Science ®Google Scholar
• Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8:915–928. doi:10.1038/nrc2536
   PubMed Web of Science ®Google Scholar
• van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 2009;18:2569–2578. doi:10.1158/1055-9965.EPI-09-0372
   PubMed Web of Science ®Google Scholar
• Morita T, Tabata S, Mineshita M, et al. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the self- defense forces health study. Asian Pac J Cancer Prev. 2005;6:485–489.
   PubMedGoogle Scholar
• Mendonça FM, de Sousa FR, Barbosa AL, et al. Metabolic syndrome and risk of cancer: which link? Metabolism. 2015;64(2):182–189. doi:10.1016/j.metabol.2014.10.008
   PubMed Web of Science ®Google Scholar
• Mardilovich K, Pankratz SL, Shaw LM. Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal. 2009;7:14. doi:10.1186/1478-811X-7-14
   PubMed Web of Science ®Google Scholar
• Arcidiacono B, Iiritano S, Nocera A, et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;2012:1–12. doi:10.1155/2012/789174
   Google Scholar
• Xu XC. COX-2 inhibitors in cancer treatment and prevention a recent development. Anticancer Drugs. 2002;13:127–137. doi:10.1097/00001813-200202000-00003
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359. doi:10.1001/jama.287.3.356
   PubMed Web of Science ®Google Scholar
• Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer. 2008;44:293–297. doi:10.1016/j.ejca.2007.11.005
   PubMed Web of Science ®Google Scholar
• Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr. 2002;132:3456S–3464S. doi:10.1093/jn/132.11.3456S
   PubMed Web of Science ®Google Scholar
• Kucharska-Newton AM, Rosamond WD, Schroeder JC, et al. HDL-cholesterol and the incidence of lung cancer in the atherosclerosis risk in communities (ARIC) study. Lung Cancer. 2008;61:292–300. doi:10.1016/j.lungcan.2008.01.015
   PubMed Web of Science ®Google Scholar
• Shor R, Wainstein J, Oz D, et al. Low HDL levels and the risk of death sepsis and malignancy. Clin Res Cardiol. 2008;97:227–233. doi:10.1007/s00392-007-0611-z
   PubMed Web of Science ®Google Scholar
• Gaard M, Tretli S, Urdal P. Risk of breast cancer in relation to blood lipids: a prospective study of 31209 Norwegian women. Cancer Causes Control. 1994;5:501–509. doi:10.1007/BF01831377
   PubMed Web of Science ®Google Scholar
• Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:920–931. doi:10.1093/jnci/djj246
   PubMed Web of Science ®Google Scholar
• Suchanek S, Grega T, Ngo O, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22(36):8103–8111. doi:10.3748/wjg.v22.i36.8103
   PubMedGoogle Scholar
• Sturmer T, Buring JE, Lee I-M, et al. Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiol Biomarkers Prev. 2006;15:2391–2397. doi:10.1158/1055-9965.EPI-06-0391
   PubMedGoogle Scholar
• Xue F, Michels KB. Diabetes metabolic syndrome and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86:s823–s835. doi:10.1093/ajcn/86.3.823S
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Smith GD, Ebrahim S. Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women’s Heart and Health Study. Cancer Causes Control. 2004;15:267–275. doi:10.1023/B:CACO.0000024225.14618.a8
   PubMed Web of Science ®Google Scholar
• Vona-Davis L, Howard-McNatt M, Rose DP. Adiposity type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev. 2007;8:395–408. doi:10.1111/j.1467-789X.2007.00396.x
   PubMed Web of Science ®Google Scholar